×
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.24 (-0.32%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.24 (-0.32%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.24 (-0.32%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.24 (-0.32%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
NASDAQ:RWLK

ReWalk Robotics Stock Forecast, Price & News

$0.95
-0.02 (-2.31%)
(As of 07/5/2022 10:49 AM ET)
Add
Compare
Today's Range
$0.95
$0.95
50-Day Range
$0.87
$1.10
52-Week Range
$0.81
$2.78
Volume
1,667 shs
Average Volume
215,891 shs
Market Capitalization
$59.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

ReWalk Robotics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
269.4% Upside
$3.50 Price Target
Short Interest
Healthy
2.86% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.44mentions of ReWalk Robotics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$302,733 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.20) to ($0.15) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.18 out of 5 stars

Medical Sector

294th out of 1,428 stocks

Surgical Appliances & Supplies Industry

8th out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

ReWalk Robotics logo

About ReWalk Robotics (NASDAQ:RWLK) Stock

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

RWLK Stock News Headlines

100th ReWalk Exoskeleton Supplied in Germany
ReWalk Robotics Announces Share Repurchase Program
Pre-market Movers: RWLK, OTRK, EVAX, NRXP, PTON…
Is ReWalk Robotics a Buy Under $2?
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
51
Year Founded
N/A

Company Calendar

Last Earnings
5/13/2022
Today
7/05/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$3.50
High Stock Price Forecast
$3.50
Low Stock Price Forecast
$3.50
Forecasted Upside/Downside
+269.4%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Net Income
$-12,740,000.00
Net Margins
-253.78%
Pretax Margin
-252.21%

Debt

Sales & Book Value

Annual Sales
$5.97 million
Book Value
$1.43 per share

Miscellaneous

Free Float
62,089,000
Market Cap
$59.30 million
Optionable
Not Optionable
Beta
2.60














ReWalk Robotics Frequently Asked Questions

Should I buy or sell ReWalk Robotics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ReWalk Robotics stock.
View analyst ratings for ReWalk Robotics
or view top-rated stocks.

What is ReWalk Robotics' stock price forecast for 2022?

1 Wall Street analysts have issued 1-year price objectives for ReWalk Robotics' stock. Their RWLK stock forecasts range from $3.50 to $3.50. On average, they predict ReWalk Robotics' stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 269.4% from the stock's current price.
View analysts' price targets for ReWalk Robotics
or view top-rated stocks among Wall Street analysts.

How has ReWalk Robotics' stock performed in 2022?

ReWalk Robotics' stock was trading at $1.23 on January 1st, 2022. Since then, RWLK shares have decreased by 23.0% and is now trading at $0.9476.
View the best growth stocks for 2022 here
.

When is ReWalk Robotics' next earnings date?

ReWalk Robotics is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for ReWalk Robotics
.

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) released its quarterly earnings data on Friday, May, 13th. The medical device company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.02. The medical device company earned $0.88 million during the quarter, compared to analysts' expectations of $2.20 million. ReWalk Robotics had a negative trailing twelve-month return on equity of 16.81% and a negative net margin of 253.78%. During the same quarter last year, the firm earned ($0.08) earnings per share.
View ReWalk Robotics' earnings history
.

Who are ReWalk Robotics' key executives?

ReWalk Robotics' management team includes the following people:
  • Mr. Lawrence J. Jasinski BS, MBA, CEO & Director (Age 65, Pay $648.52k) (LinkedIn Profile)
  • Ms. Miri Pariente, VP of Operations, Regulatory & Quality (Age 45, Pay $321.75k)
  • Ms. Jeannine Lynch, VP of Market Access & Strategy (Age 57, Pay $422.25k)
  • Mr. David Hexner, VP of R&D
  • Mr. Almog Adar, Director of Fin. & Corp. Financial Controller (Age 38)
  • Ms. Kathleen O'Donnell, VP of Marketing & New Bus. Devel.
  • Ms. Judy Kula, VP of Customer Service, HR & Bus. Affairs
  • Mr. Ami Kraft, Exec. Advisor to the CEO (Age 79)

What other stocks do shareholders of ReWalk Robotics own?

What is ReWalk Robotics' stock symbol?

ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

How do I buy shares of ReWalk Robotics?

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ReWalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $0.95.

How much money does ReWalk Robotics make?

ReWalk Robotics (NASDAQ:RWLK) has a market capitalization of $59.30 million and generates $5.97 million in revenue each year. The medical device company earns $-12,740,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis.

How many employees does ReWalk Robotics have?

ReWalk Robotics employs 51 workers across the globe.

How can I contact ReWalk Robotics?

ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The official website for ReWalk Robotics is www.rewalk.com. The medical device company can be reached via phone at (724) 959-0123 or via email at ir@rewalk.com.

This page (NASDAQ:RWLK) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.